{"version":"1.0","provider_name":"BROAD NEWS \u2014 WITHIN NIGERIA","provider_url":"https:\/\/www.withinnigeria.com\/broadnews","author_name":"Damilare Aanu","author_url":"https:\/\/www.withinnigeria.com\/broadnews\/author\/dare_oke\/","title":"GlaxoSmithKline agrees to buy Sierra Oncology","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"H4xEcRuNLV\"><a href=\"https:\/\/www.withinnigeria.com\/broadnews\/2022\/04\/13\/glaxosmithkline-agrees-to-buy-sierra-oncology\/\">GlaxoSmithKline agrees to buy Sierra Oncology<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.withinnigeria.com\/broadnews\/2022\/04\/13\/glaxosmithkline-agrees-to-buy-sierra-oncology\/embed\/#?secret=H4xEcRuNLV\" width=\"600\" height=\"338\" title=\"&#8220;GlaxoSmithKline agrees to buy Sierra Oncology&#8221; &#8212; BROAD NEWS \u2014 WITHIN NIGERIA\" data-secret=\"H4xEcRuNLV\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.withinnigeria.com\/broadnews\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/www.withinnigeria.com\/broadnews\/wp-content\/uploads\/sites\/11\/Screenshot_20220413-193145.png","thumbnail_width":686,"thumbnail_height":714,"description":"British pharmaceuticals producer GlaxoSmithKline has agreed to buy late-stage biopharmaceutical company Sierra Oncology. GlaxoSmithKline said on Wednesday that it would pay 55 dollars per share of common stock in cash, representing an approximate total equity value of 1.9 billion dollars. The acquisition is to be carried out through a one-step merger in which the outstanding [&hellip;]"}